ABT Abbott Laboratories Stock Quote

ABT [NYSE]

Index	S&P 500	P/E	31.02	EPS (ttm)	4.06	Insider Own	0.20%	Shs Outstand	1.77B	Perf Week	-1.38%
Market Cap	224.00B	Forward P/E	26.62	EPS next Y	4.73	Insider Trans	-7.27%	Shs Float	1.76B	Perf Month	-1.43%
Income	7.27B	PEG	2.36	EPS next Q	1.33	Inst Own	75.50%	Short Float	0.64%	Perf Quarter	1.04%
Sales	42.31B	P/S	5.29	EPS this Y	24.50%	Inst Trans	-0.08%	Short Ratio	2.26	Perf Half Y	7.91%
Book/sh	19.40	P/B	6.49	EPS next Y	-6.67%	ROA	9.90%	Target Price	138.61	Perf Year	18.30%
Cash/sh	5.45	P/C	23.11	EPS next 5Y	13.12%	ROE	21.50%	52W Range	105.32 - 131.60	Perf YTD	14.97%
Dividend	1.80	P/FCF	35.73	EPS past 5Y	7.80%	ROI	9.70%	52W High	-4.35%	Beta	0.68
Dividend %	1.43%	Quick Ratio	1.40	Sales past 5Y	11.10%	Gross Margin	56.90%	52W Low	19.52%	ATR	2.34
Employees	109000	Current Ratio	1.80	Sales Q/Q	23.40%	Oper. Margin	20.10%	RSI (14)	49.36	Volatility	1.83% 1.65%
Optionable	Yes	Debt/Eq	0.53	EPS Q/Q	70.30%	Profit Margin	17.10%	Rel Volume	0.93	Prev Close	125.07
Shortable	Yes	LT Debt/Eq	0.51	Earnings	Oct 20 BMO	Payout	41.90%	Avg Volume	4.98M	Price	125.88
Recom	1.90	SMA20	-1.29%	SMA50	1.73%	SMA200	4.30%	Volume	4,648,610	Change	0.65%

Oct-27-21

Upgrade

Atlantic Equities

Neutral → Overweight

$144

Oct-14-21

Initiated

Redburn

Neutral

May-25-21

Initiated

Barclays

Overweight

$150

Apr-15-21

Initiated

Atlantic Equities

Neutral

$122

Jan-28-21

Upgrade

BTIG Research

Neutral → Buy

$140

Sep-11-20

Initiated

Wolfe Research

Outperform

$124

Jun-01-20

Downgrade

Goldman

Neutral → Sell

$84

Mar-05-20

Initiated

Citigroup

Buy

$96

Feb-13-20

Initiated

Goldman

Neutral

$96

Feb-06-20

Resumed

BTIG Research

Neutral

Jan-02-20

Downgrade

Guggenheim

Buy → Neutral

Jun-13-19

Reiterated

BofA/Merrill

Buy

$81 → $90

Feb-07-19

Reiterated

BofA/Merrill

Buy

$73 → $81

Jan-02-19

Downgrade

Citigroup

Neutral → Sell

Nov-30-18

Upgrade

Goldman

Neutral → Buy

Oct-16-18

Initiated

Barclays

Overweight

$80

Jun-27-18

Initiated

Bernstein

Outperform

$73

Jan-30-18

Reiterated

Citigroup

Neutral

$59 → $64

Jan-25-18

Upgrade

William Blair

Mkt Perform → Outperform

Jan-25-18

Reiterated

Stifel

Buy

$63 → $71

Nov-26-21 08:17AM	Here's Why You Should Retain Abbott (ABT) Stock For Now Zacks
Nov-19-21 11:30AM	Why Is Abbott (ABT) Up 2.1% Since Last Earnings Report? Zacks
Nov-18-21 08:02AM	Abbott Named to the Corporate Citizenship Hall of Fame News Direct
Nov-17-21 09:25AM	Abbott (ABT) Introduces New Next-Generation Infant Formula Zacks
05:58AM	Better Buy: DexCom or Abbott Labs? Motley Fool
05:55AM	Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows Motley Fool
Nov-16-21 03:17PM	Stocks To Buy And Watch Actionable Now: 3 Leaders Hit New Highs, Including Home Depot Investor's Business Daily
01:00PM	Abbott Launches Similac® 360 Total Care® with Exclusive Blend of Five HMO Prebiotics and Designed to Support the Immune System, Digestive Health and Brain Development PR Newswire
08:36AM	Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on the Dow Jones Sustainability Index (DJSI) News Direct
07:57AM	Abbott (ABT) Scales to a 52-Week High: What's Driving It? Zacks
Nov-15-21 10:48AM	Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on the Dow Jones Sustainability Index (DJSI) PR Newswire
08:53AM	Abbott (ABT) Aveir System Meets Primary Pivotal Trial Endpoints Zacks
06:01AM	10 Best Biotech Stocks to Buy According to Mark Lamperts Biotechnology Value Fund Insider Monkey
Nov-12-21 11:39AM	The Johnson & Johnson split makes sense as it moves into more innovative products: Analyst Yahoo Finance Video
09:08AM	A (Virtual) Field Trip Into the Heart News Direct
09:00AM	Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial PR Newswire
Nov-11-21 07:28AM	The Zacks Analyst Blog Highlights: Alibaba, Abbott Laboratories, T-Mobile, Anheuser-Busch and Boston Scientific Corp Zacks
06:55AM	11 Best Healthcare Stocks To Invest In Insider Monkey
06:25AM	2 Dividend Aristocrats That Could Announce Generous Rate Hikes in December Motley Fool
05:41AM	A Look At The Fair Value Of Abbott Laboratories (NYSE:ABT) Simply Wall St.
Nov-10-21 12:47PM	Top Analyst Reports for Alibaba, Abbott & T-Mobile US Zacks
10:00AM	Why Abbott (ABT) is a Top Momentum Stock for the Long-Term Zacks
Nov-09-21 09:00AM	Abbott and the American Diabetes Association® Launch First-of-Its-Kind Community Initiative in Columbus, Ohio, to Advance Access to Diabetes Care and Technology PR Newswire
Nov-08-21 08:04AM	Explore the Human Heart: New Virtual Field Trip Premieres Tuesday, Nov. 9 News Direct
Nov-05-21 08:21AM	Engineer Becomes a Mother While Responding to Pandemic News Direct
Nov-03-21 01:01PM	Abbott Launches New Initiative to Drive Diversity in Medical Research and Improve Care Among Under-Represented Populations News Direct
09:00AM	Abbott Launches New Initiative to Drive Diversity in Medical Research and Improve Care Among Under-Represented Populations PR Newswire
Nov-02-21 10:14AM	Was The Smart Money Right About Abbott Laboratories (ABT)? Insider Monkey
Oct-29-21 08:17AM	Real Sustainability Is About People News Direct
Oct-28-21 10:29AM	4 Medical Products Stocks Poised to Beat This Earnings Season Zacks
09:59AM	CONMED's (CNMD) Q3 Earnings Beat Estimates, Revenues Miss Zacks
09:57AM	West Pharmaceutical (WST) Q3 Earnings & Revenues Beat Estimates Zacks
09:47AM	Baxter (BAX) Q3 Earnings and Revenues Surpass Estimates Zacks
09:22AM	Abiomed (ABMD) Beats on Q2 Earnings, Lowers FY22 Guidance Zacks
Oct-27-21 03:37PM	Abbott Named One the 100 Best ESG Companies by Investor's Business Daily News Direct
12:20PM	Earnings Estimates Rising for Abbott (ABT): Will It Gain? Zacks
11:48AM	In Q3 earnings, Boston Scientific acknowledges Covid-19 headwinds American City Business Journals
09:02AM	Masimo's (MASI) Q3 Earnings Surpass Estimates, '21 View Up Zacks
Oct-26-21 11:30AM	Has Abbott Laboratories (ABT) Outpaced Other Medical Stocks This Year? Zacks
11:00AM	Got $5,000? These 2 Unstoppable Stocks Are No-Brainer Buys Motley Fool
01:00AM	Analysts say Boston Scientific faces 'higher level of exposure' to risk American City Business Journals
Oct-25-21 11:44AM	Abbott's (ABT) Organic Sales Grow Amid Spike in COVID Cases Zacks
09:26AM	Podcast: How to Turn STEM Curiosity Into a Career News Direct
Oct-21-21 12:33PM	10 Stocks Making Moves on Financial Results Insider Monkey
05:52AM	3 Things Investors Should Love About Abbott's Q3 Results Motley Fool
04:58AM	Abbott Exceeds Q3 Expectations; Shares Jump 3.3% SmarterAnalyst
Oct-20-21 04:56PM	US STOCKS-Wall Street closes higher as earnings reports soothe investor fears Reuters
04:34PM	Why Abbott Laboratories Shot Higher Today Motley Fool
04:09PM	Abbott Labs Stock Leapfrogs A Key Line Despite A Wild Card Obscuring 2022 Investor's Business Daily
04:01PM	REFILE-US STOCKS-Wall Street closes higher as earnings reports soothe investor fears Reuters
03:10PM	US STOCKS-S&P 500, Dow near records as earnings reports soothe investor fears Reuters
02:00PM	Abbott Laboratories (ABT) Q3 2021 Earnings Call Transcript Motley Fool
12:20PM	US STOCKS-S&P 500, Dow near record highs on solid forecasts from healthcare firms Reuters
10:46AM	Pre-Markets Opens Flat Zacks
10:36AM	Markets Flat as Q3 Earnings Continue: VZ, ABT, TSLA & More Zacks
10:35AM	Novavax vaccine delays slump stock, Abbott Labs raises guidance, Biogen beats Q3 estimates Yahoo Finance Video
10:29AM	Abbott's (ABT) Q3 Earnings Beat Estimates, 2021 Guidance Up Zacks
10:08AM	US STOCKS-Wall St grinds higher on solid healthcare earnings; supply woes linger Reuters
10:01AM	Why Abbott Shares Are Rising Today Benzinga
08:45AM	Abbott (ABT) Q3 Earnings and Revenues Beat Estimates Zacks
08:05AM	Abbott Labs Earnings Beat Estimates. Its Stock Is Rising. Barrons.com
07:44AM	Abbott Laboratories stock surges after big profit and sales beats, and upbeat full-year outlook MarketWatch
07:43AM	UPDATE 3-Abbott raises annual earnings outlook as COVID-19 test sales rebound Reuters
07:36AM	Abbott raises annual earnings outlook as COVID-19 test sales rebound Reuters
07:30AM	Abbott Reports Third-Quarter 2021 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance PR Newswire
06:30AM	Abbott Labs Earnings Are Astounding! Here's My Trade Idea TheStreet.com
05:24AM	Alibaba, Verizon Rise in Premarket; Netflix Falls Investing.com
05:09AM	Abbott Jumps as Covid Tests Boost Earnings, Guidance Investing.com
Oct-19-21 05:30PM	5 Must-See Earnings Charts This Week Zacks
01:36PM	Abbott and Real Madrid Team Up to Support the Health and Nutrition of Children Globally News Direct
10:50AM	Abbott's (ABT) Nutrition Arm in Focus on Real Madrid Alliance Zacks
Oct-18-21 11:13AM	How Abbott's partnership with Real Madrid is helping to 'support kids worldwide' Yahoo Finance Video
09:22AM	Jason Sudeikis Joins Abbott, Real Madrid at New York Stock Exchange to Support Children's Health PR Newswire
08:49AM	Why Earnings Season Could Be Great for Abbott (ABT) Zacks
07:00AM	Abbott and Real Madrid Team Up to Support the Health and Nutrition of Children Globally PR Newswire
Oct-17-21 06:30AM	3 Solid Growth Stocks Perfect for Retirees Motley Fool
Oct-16-21 08:10AM	Abbott Laboratories' (NYSE:ABT) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? Simply Wall St.
Oct-15-21 11:15AM	PerkinElmer (PKI) Receives EUA from FDA for Latest Assay Zacks
09:35AM	FDA: Abbott is recalling two lab-based COVID-19 tests due to the possibility of false positive results MarketWatch
08:50AM	This 1 Medical Stock Could Beat Earnings: Why It Should Be on Your Radar Zacks
Oct-14-21 05:50PM	Abbott (ABT) Gains But Lags Market: What You Should Know Zacks
05:27PM	UPDATE 1-Abbott Labs unit recalling two COVID-19 lab test kits - FDA Reuters
04:18PM	Abbott Labs unit recalling two COVID-19 test kits - FDA Reuters
11:04AM	BD's (BDX) Rotarex Atherectomy System Gets FDA 510 (k) Clearance Zacks
09:04AM	Boston Scientific (BSX) Inks New Deal to Buy Baylis Medical Zacks
06:11AM	10 Monthly Dividend Covered Call ETFs and ETNs You Can Count On Insider Monkey
05:51AM	The Zacks Analyst Blog Highlights: Abbott Laboratories, UnitedHealth, Quest, and West Pharmaceutical Zacks
Oct-13-21 03:01PM	Analysts Estimate Abbott (ABT) to Report a Decline in Earnings: What to Look Out for Zacks
11:10AM	PerkinElmer's (PKI) Arm Gets FDA EUA Nod for Latest Assay Zacks
10:44AM	[video]Can Abbott Labs Get Its Act Together? TheStreet.com
08:10AM	Growing COVID-19 Testing Demand to Boost Abbott's (ABT) Q3 Earnings Zacks
Oct-12-21 10:00AM	Hologic (HOLX) Launches Novodiag System for On-Demand Testing Zacks
09:10AM	Boston Scientific's (BSX) Ranger DCB Trial Outcome Favorable Zacks
Oct-08-21 05:36AM	10 Best Big Pharma Stocks to Buy Now Insider Monkey
Oct-07-21 05:50PM	Abbott (ABT) Outpaces Stock Market Gains: What You Should Know Zacks
Oct-05-21 02:58PM	Abbott says at-home COVID tests will be widely available again by end of October Yahoo Finance
11:16AM	How Abbott Labs vision for health care and digital tech is coming together Yahoo Finance Video
11:15AM	Yahoo Finance Presents: Abbott President & CEO Robert Ford Yahoo Finance Video
11:00AM	Abbott is first health care company to keynote at CES Yahoo Finance
11:00AM	Abbott (ABT) Gets FDA Nod for Amplatzer Talisman System Zacks

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Meniere's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. It has collaboration agreement with Cereno Scientific AB (publ). The company was founded in 1888 and is based in North Chicago, Illinois.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Nov 15	Option Exercise	41.84	12,500	523,000	62,282	Nov 17 06:18 PM
Ahlberg Gregory A	SENIOR VICE PRESIDENT	Nov 15	Option Exercise	58.16	36,935	2,148,124	46,855	Nov 17 06:11 PM
Ahlberg Gregory A	SENIOR VICE PRESIDENT	Nov 15	Sale	130.00	25,473	3,311,490	15,920	Nov 17 06:11 PM
LANE ANDREW H	EXECUTIVE VICE PRESIDENT	Nov 15	Sale	130.01	10,000	1,300,090	76,087	Nov 17 06:22 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Nov 15	Sale	130.01	12,500	1,625,111	49,782	Nov 17 06:18 PM
Ginascol John F	EXECUTIVE VICE PRESIDENT	Oct 27	Option Exercise	47.00	45,709	2,148,323	143,262	Oct 27 06:45 PM
OSBORN WILLIAM A	Director	Oct 26	Option Exercise	59.42	15,752	935,984	96,996	Oct 27 06:37 PM
Boudreau Philip P	VICE PRESIDENT	Oct 25	Sale	126.49	8,000	1,011,920	16,876	Oct 27 06:22 PM
PEDERSON MICHAEL J	SENIOR VICE PRESIDENT	Sep 08	Option Exercise	50.72	23,008	1,166,966	85,579	Sep 10 06:13 PM
PEDERSON MICHAEL J	SENIOR VICE PRESIDENT	Sep 08	Sale	129.05	23,008	2,969,173	62,571	Sep 10 06:13 PM
WOODGRIFT RANDEL WILLIAM	SENIOR VICE PRESIDENT	Sep 03	Option Exercise	38.40	1,000	38,400	50,093	Sep 08 05:28 PM
WOODGRIFT RANDEL WILLIAM	SENIOR VICE PRESIDENT	Sep 03	Sale	129.00	6,350	819,150	43,743	Sep 08 05:28 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Sep 02	Option Exercise	42.47	9,500	403,500	59,282	Sep 03 05:20 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Sep 02	Sale	127.50	9,500	1,211,250	49,782	Sep 03 05:20 PM
LANE ANDREW H	EXECUTIVE VICE PRESIDENT	Aug 27	Option Exercise	38.40	135,925	5,219,520	222,012	Aug 31 05:18 PM
LANE ANDREW H	EXECUTIVE VICE PRESIDENT	Aug 27	Sale	125.47	135,925	17,055,189	86,087	Aug 31 05:18 PM
Karam Sammy	SENIOR VICE PRESIDENT	Aug 17	Option Exercise	75.90	8,000	607,200	30,926	Aug 19 06:29 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Aug 17	Option Exercise	41.07	14,500	595,500	64,282	Aug 19 06:27 PM
Karam Sammy	SENIOR VICE PRESIDENT	Aug 17	Sale	125.00	8,000	1,000,000	22,926	Aug 19 06:29 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Aug 17	Sale	125.00	14,500	1,812,500	49,782	Aug 19 06:27 PM
Karam Sammy	SENIOR VICE PRESIDENT	Aug 03	Option Exercise	75.90	8,000	607,200	30,926	Aug 05 05:40 PM
Karam Sammy	SENIOR VICE PRESIDENT	Aug 03	Sale	122.50	8,000	980,000	22,926	Aug 05 05:40 PM
DALE MICHAEL D	SENIOR VICE PRESIDENT	Jul 28	Option Exercise	50.72	17,600	892,672	57,291	Jul 30 05:21 PM
DALE MICHAEL D	SENIOR VICE PRESIDENT	Jul 28	Sale	120.33	17,600	2,117,882	39,691	Jul 30 05:21 PM
Watkin Jared	SENIOR VICE PRESIDENT	Apr 30	Option Exercise	56.83	85,043	4,832,629	144,826	May 04 07:07 PM
Watkin Jared	SENIOR VICE PRESIDENT	Apr 30	Sale	119.90	94,576	11,339,739	59,783	May 04 07:07 PM
Karam Sammy	SENIOR VICE PRESIDENT	Apr 27	Option Exercise	75.90	8,600	652,740	31,526	Apr 29 06:42 PM
Karam Sammy	SENIOR VICE PRESIDENT	Apr 27	Sale	122.00	8,600	1,049,200	22,926	Apr 29 06:42 PM
BIRD ROGER	SENIOR VICE PRESIDENT	Apr 27	Sale	122.00	9,439	1,151,558	51,083	Apr 29 06:38 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Mar 03	Sale	121.79	6,200	755,098	51,550	Mar 05 07:11 PM
WOODGRIFT RANDEL WILLIAM	SENIOR VICE PRESIDENT	Mar 01	Sale	120.61	1,034	124,711	50,461	Mar 02 08:11 PM
Watkin Jared	SENIOR VICE PRESIDENT	Mar 01	Sale	120.61	1,391	167,769	69,316	Mar 02 08:01 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Mar 01	Sale	120.61	587	70,798	57,750	Mar 02 07:59 PM
Salvadori Daniel Gesua Sive	EXECUTIVE VICE PRESIDENT	Mar 01	Sale	120.61	1,664	200,695	107,430	Mar 02 07:54 PM
Ginascol John F	EXECUTIVE VICE PRESIDENT	Mar 01	Sale	120.61	352	42,455	99,321	Mar 02 07:30 PM
Earnhardt Lisa D	EXECUTIVE VICE PRESIDENT	Mar 01	Sale	120.61	943	113,735	82,375	Mar 02 07:16 PM
DALE MICHAEL D	SENIOR VICE PRESIDENT	Mar 01	Sale	120.61	1,475	177,900	39,691	Mar 02 07:13 PM
BRYNELSEN CHARLES	SENIOR VICE PRESIDENT	Mar 01	Sale	120.61	1,002	120,851	43,550	Mar 02 07:02 PM
BIRD ROGER	SENIOR VICE PRESIDENT	Mar 01	Sale	120.61	1,113	134,239	60,522	Mar 02 06:55 PM
Ahlberg Gregory A	SENIOR VICE PRESIDENT	Mar 01	Sale	120.61	1,052	126,882	14,045	Mar 02 06:49 PM
Kumbier Michelle	Director	Feb 23	Buy	122.50	2,040	249,900	7,296	Feb 25 06:05 PM
Moreland Mary K	EXECUTIVE VICE PRESIDENT	Feb 22	Sale	121.83	400	48,734	75,706	Feb 23 07:05 PM
Moreland Mary K	EXECUTIVE VICE PRESIDENT	Feb 16	Sale	128.49	505	64,887	63,373	Feb 18 05:57 PM
Funck Robert E	EXECUTIVE VICE PRESIDENT	Feb 02	Option Exercise	39.12	31,325	1,225,434	193,542	Feb 04 06:56 PM
MANNING JOSEPH J	SENIOR VICE PRESIDENT	Feb 02	Sale	123.03	3,130	385,084	59,681	Feb 03 07:20 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Feb 01	Option Exercise	38.78	203,393	7,887,902	355,289	Feb 03 07:10 PM
Scoggins Christopher J	SENIOR VICE PRESIDENT	Feb 01	Option Exercise	44.83	45,000	2,017,200	84,706	Feb 03 07:14 PM
MANNING JOSEPH J	SENIOR VICE PRESIDENT	Feb 01	Option Exercise	38.40	18,750	720,000	81,561	Feb 03 07:20 PM
MANNING JOSEPH J	SENIOR VICE PRESIDENT	Feb 01	Sale	122.79	18,750	2,302,264	62,811	Feb 03 07:20 PM
Scoggins Christopher J	SENIOR VICE PRESIDENT	Feb 01	Sale	123.24	45,000	5,545,800	39,706	Feb 03 07:14 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Feb 01	Sale	123.47	203,393	25,113,252	151,896	Feb 03 07:10 PM
NOVAKOVIC PHEBE N	Director	Dec 04	Option Exercise	34.97	14,681	513,431	45,794	Dec 08 05:58 PM
NOVAKOVIC PHEBE N	Director	Dec 04	Sale	107.28	4,790	513,849	41,004	Dec 08 05:58 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience